Sustained Effectiveness of Rotavirus Vaccine Against Very Severe Rotavirus Disease Through the Second Year of Life, Bolivia 2013–2014

Simple item page
dc.contributor.authorKimberly Pringle
dc.contributor.authorMaritza Patzi
dc.contributor.authorJacqueline E. Tate
dc.contributor.authorVolga Iñiguez Rojas
dc.contributor.authorManish M. Patel
dc.contributor.authorLucia Inchauste Jordan
dc.contributor.authorRaúl Montesano
dc.contributor.authorAdolfo Zarate
dc.contributor.authorLúcia de Oliveira
dc.contributor.authorUmesh D. Parashar
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:11:54Z
dc.date.available2026-03-22T14:11:54Z
dc.date.issued2016
dc.descriptionCitaciones: 32
dc.description.abstractA monovalent rotavirus vaccine remains effective against a broad range of circulating strains as part of a routine immunization program >5 years after its introduction in Bolivia. Although VE appears to wane in children aged ≥1 year, it still provides significant protection, and does not wane against severe disease.
dc.identifier.doi10.1093/cid/civ1026
dc.identifier.urihttps://doi.org/10.1093/cid/civ1026
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45109
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofClinical Infectious Diseases
dc.sourceNational Center for Immunization and Respiratory Diseases
dc.subjectMedicine
dc.subjectRotavirus
dc.subjectRotavirus vaccine
dc.subjectVirology
dc.subjectRotavirus Infections
dc.subjectReoviridae
dc.titleSustained Effectiveness of Rotavirus Vaccine Against Very Severe Rotavirus Disease Through the Second Year of Life, Bolivia 2013–2014
dc.typearticle

Files

Collections

Artículo Científico Publicado